Raras
Buscar doenças, sintomas, genes...
Ganglioneuroblastoma
ORPHA:251877CID-10 · C71.9CID-11 · 2A00.11DOENÇA RARA

Tumor neuroblástico caracterizado pela presença de células neuroblásticas, células ganglionares e um estroma com diferenciação Schwanniana constituindo mais de cinquenta por cento do volume do tumor. Existem dois subtipos histológicos identificados: ganglioneuroblastoma misto e ganglioneuroblastoma nodular.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Tumor neuroblástico caracterizado pela presença de células neuroblásticas, células ganglionares e um estroma com diferenciação Schwanniana constituindo mais de cinquenta por cento do volume do tumor. Existem dois subtipos histológicos identificados: ganglioneuroblastoma misto e ganglioneuroblastoma nodular.

Pesquisas ativas
17 ensaios
23 total registrados no ClinicalTrials.gov
Publicações científicas
914 artigos
Último publicado: 2026 Mar 20

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
425
pacientes catalogados
Início
Childhood
+ infancy
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: C71.9
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico914PubMed
Últimos 10 anos200publicações
Pico202341 papers
Linha do tempo
2026Hoje · 2026🧪 2000Primeiro ensaio clínico📈 2023Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Not applicable.

ALKALK tyrosine kinase receptorMajor susceptibility factor inRestrito
FUNÇÃO

Neuronal receptor tyrosine kinase that is essentially and transiently expressed in specific regions of the central and peripheral nervous systems and plays an important role in the genesis and differentiation of the nervous system (PubMed:11121404, PubMed:11387242, PubMed:16317043, PubMed:17274988, PubMed:30061385, PubMed:34646012, PubMed:34819673). Also acts as a key thinness protein involved in the resistance to weight gain: in hypothalamic neurons, controls energy expenditure acting as a nega

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Signaling by ALKMDK and PTN in ALK signaling
OUTRAS DOENÇAS (9)
large congenital melanocytic nevusneuroblastomaganglioneuroblastomadifferentiated thyroid carcinoma
HGNC:427UniProt:Q9UM73

Variantes genéticas (ClinVar)

4,870 variantes patogênicas registradas no ClinVar.

🧬 ALK: NM_004304.5(ALK):c.793G>A (p.Glu265Lys) ()
🧬 ALK: NM_004304.5(ALK):c.1546+18C>T ()
🧬 ALK: NM_004304.5(ALK):c.2752_2754del (p.Arg918del) ()
🧬 ALK: NM_004304.5(ALK):c.1912+10C>A ()
🧬 ALK: NM_004304.5(ALK):c.595G>C (p.Gly199Arg) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 3 variantes classificadas pelo ClinVar.

3
Patogênica (100.0%)
VARIANTES MAIS SIGNIFICATIVAS
BRAF: NM_004333.6(BRAF):c.1799T>A (p.Val600Glu) [Conflicting classifications of pathogenicity]
PHOX2B: NM_003924.4(PHOX2B):c.676del (p.Ala226fs) [Pathogenic]
PHOX2B: NM_003924.4(PHOX2B):c.421C>G (p.Arg141Gly) [Pathogenic]
ATRX: NM_000489.6(ATRX):c.2518dup (p.Arg840fs) []
ALK: NM_004304.5(ALK):c.3455_3457del (p.Leu1152del) []

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 35
2Fase 25
1Fase 15
·Pré-clínico5
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Ganglioneuroblastoma

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

8 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

23 ensaios clínicos encontrados, 17 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
313 papers (10 anos)
#1

[Correlation study between tumor location and pathological subtypes of neuroblastic tumors associated with opsoclonus myoclonus ataxia syndrome].

Zhonghua er ke za zhi = Chinese journal of pediatrics2026 Mar 14

Objective: To analyze the correlation between the location and pathological subtypes of of neuroblastic tumors (NBT) associated with opsoclonus myoclonus ataxia syndrome (OMAS). Methods: A case-control study. Clinical data of 34 pediatric patients diagnosed with NBT complicated by OMAS (NBT-OMAS group), who were hospitalized in the Department of Pediatrics, Peking University First Hospital from January 2007 and December 2022 were collected retrospectively. The control group consisted of 34 age and sex-matched patients with NBT only (NBT-only group) admitted during the same period. Chi-square test or Fisher exact test was used to compare the distribution of tumor locations and pathological subtypes between the two groups. Cramer's V coefficient was applied to analyze the correlation between them. The outcomes of the patients were followed up. Results: The age of patients in the NBT-OMAS group was 18 (12, 28) months, while that of the NBT-only group was 20 (13, 31) months. In the NBT-OMAS group, 28 cases (82%) had tumors located in the paraspinal sympathetic chain and 6 cases (18%) in the adrenal glands. In the NBT-only group, 6 cases (18%) had tumors located in the adrenal glands and 28 cases (82%) in the paraspinal sympathetic chain, with a statistically significant difference between the two groups (χ2=10.69, P<0.01). The distribution of pathological subtypes of tumors in the NBT-OMAS group was as follows: 20 cases (59%) of ganglioneuroblastoma (GNB), 10 cases (29%) of neuroblastoma (NB), 4 cases (12%) of ganglioneuroma (GN). In the NBT-only group, NB was predominant with 21 cases (62%), GNB in 13 cases (38%), and no GN subtype was observed. There was a statistically significant difference between the two groups (χ2=8.59, P<0.01). In the NBT-OMAS group, the pathological subtype of tumors located in the adrenal gland was mainly NB, with 5 cases (5/6). For tumors located paravertebral to the thoracic and lumbar spine, the predominant subtype was GNB, with 8 cases (8/11) and 11 cases (11/13) respectively. As for tumors paravertebral to the sacral spine, the major subtype was NB, with 3 cases (3/4). In the NBT-only group, NB was the pathological subtype in 18 cases of adrenal gland tumors (18/19). For tumors paravertebral to the cervical spine, NB and GNB each accounted for 2 cases respectively (2/4). Tumors located paravertebral to the thoracic spine and paravertebral to the lumbar spine were all GNB for 5 cases (5/5), while those paravertebral to the sacral spine were all NB for 1 case (1/1). The Cramer's V coefficients of the tumor location and pathological subtype in the two groups were 0.65 and 0.81, respectively. The follow-up ended on December 31, 2023. In the NBT-OMAS group, 1 case had tumor recurrence and 1 case died due to tumor progression; both the recurrent and fatal tumors were located in the adrenal glands with the pathological subtype of NB. In the NBT-only group, 11 cases died of tumor progression, among which 8 cases had primary tumor located in the adrenal gland and with the pathological subtype of NB. Conclusions: In children with NBT-OMAS, tumors located in the paravertebral sympathetic chains are significantly more common than those in the adrenal gland, the pathological subtype of tumors was predominantly GNB. The tumor location was correlated with its pathological subtype. 目的: 分析并发眼阵挛肌阵挛共济失调综合征(OMAS)的神经母细胞肿瘤(NBT)肿瘤发生部位与病理亚型的相关性。 方法: 病例对照研究。收集2007年1月至2022年12月在北京大学第一医院儿科住院且明确诊断为NBT并发OMAS的34例患儿(NBT-OMAS组)临床资料,对照组为同期入院、年龄和性别都匹配的单纯NBT患儿34例(单纯NBT组),采用χ2 检验或Fisher确切概率法比较两组肿瘤发生部位、病理亚型的分布情况,通过Cramer′s V系数比较两者的相关性,随访患儿结局。 结果: NBT-OMAS组患儿年龄18(12,28)月龄,单纯NBT组年龄为20(13,31)月龄。NBT-OMAS组肿瘤发生于脊柱旁交感神经链者28例(82%)、肾上腺者6例(18%);单纯NBT组中发生于肾上腺和脊柱旁交感神经链者分别为19例(56%)和15例(44%),两组比较差异有统计学意义(χ2=10.69,P<0.01)。NBT-OMAS组肿瘤病理亚型分布为节细胞神经母细胞瘤(GNB)20例(59%),神经母细胞瘤(NB)10例(29%),节细胞神经瘤(GN)4例(12%);单纯NBT组病理类型主要为NB 21例(62%),GNB 13例(38%),无GN亚型,两组比较差异有统计学意义(χ2=8.59,P<0.01)。NBT-OMAS组中,6例肿瘤位于肾上腺者中5例为NB;11例位于胸椎旁者中8例为GNB;13例位于腰椎旁者中11例为GNB;4例位于骶椎旁者中3例为NB。单纯NBT组中,19例肿瘤位于肾上腺中18例为NB;4例位于颈椎旁者中NB和GNB各占2例;5例位于胸椎旁和5例位于腰椎旁者均为GNB;1例位于骶椎旁者为NB。两组肿瘤所在部位与其病理亚型的Cramer′s V系数分别为0.65、0.81。随访截至2023年12月31日,NBT-OMAS组1例肿瘤复发、1例因肿瘤进展死亡,肿瘤均位于肾上腺且病理亚型为NB;单纯NBT组有11例因肿瘤进展死亡,其中8例原发肿瘤位于肾上腺且病理亚型为NB。 结论: NBT-OMAS患儿肿瘤发生于脊柱旁交感神经链者明显多于肾上腺者;肿瘤病理亚型以GNB者为主;肿瘤发生部位与其病理亚型相关。.

#2

Temporal clustering of neuroblastic tumours in children and young adults from Scotland.

Environmental health : a global access science source2026 Jan 24

Neuroblastic tumours (neuroblastoma and ganglioneuroblastoma) are the most common childhood solid tumours outside the central nervous system, with a median age of diagnosis of 2 years. Temporal clustering of neuroblastic tumours in northern England and Ontario, Canada has been previously reported. We extracted data from the Scottish Cancer Registry to determine whether there was evidence of temporal clustering of neuroblastic tumours. Cases diagnosed in children and young adults aged 0-24 years between 2000 and 2020 were analysed. A modified version of the Potthoff-Whittinghill method was used to test for temporal clustering. Estimates of extra-Poisson variation (EPV) and standard errors (SE) were derived. One hundred and sixty-one cases of neuroblastic tumours, aged 0-24 years, were diagnosed during the study period. Overall, there was statistically significant temporal clustering between years within the full study period (EPV = 9.13, SE = 0.22, P < 0.001). In addition, for cases aged < 18 months, there was significant temporal clustering between months within quarters (EPV = 0.77, SE = 0.41, P = 0.044). For cases aged 18 months - 24 years, there was significant temporal clustering between fortnights within months (EPV = 1.00, SE = 0.47, P = 0.012). The finding of temporal clustering is consistent with the involvement of one or more, as yet unknown, transient environmental agents in the aetiology of neuroblastic tumours.

#3

Telomere maintenance mechanisms are activated in ganglioneuroblastoma and ganglioneuroma.

Oncology letters2026 May

Telomere maintenance mechanisms (TMM) have garnered attention as a mechanism associated with the treatment resistance and poor prognosis of neuroblastoma (NB). Ganglioneuroblastoma (GNB) and ganglioneuroma (GN) are histologically classified as neuroblastic tumors (NTs) along with NB; however, few reports have addressed TMM in GNB and GN. The present study analyzed 321 NTs diagnosed in Japan, including 255 NB cases, 48 GNB cases and 18 GN cases, using a quantitative PCR-based C-circle assay for alternative lengthening of telomeres (ALT) and a telomerase reverse transcriptase (TERT) mRNA expression assay. ALT was identified in 38 NB cases (38/255, 15%) and 6 GNB cases (6/48, 12.5%), but not in GN. High TERT expression was observed in 38% (64/169), 23% (7/31) and 14% (1/7) of NB, GNB and GN cases, respectively. TMM activation, defined as ALT(+) and/or high TERT expression, occurred in 12/48 GNB cases and 1/18 GN cases, particularly in the GNB-nodular type (10/21, 48%), which was similar to 39% (100/255) of NB cases. Furthermore, TMM(+) GNBs exhibited distinct features, including a high frequency of ATRX alterations and a lower frequency of TERT rearrangements. Chromosomal aberration analysis revealed frequent 7q gain, 17q gain and 11q loss in ALT(+) NTs (83%). Overall, TMM serves as a poor prognostic marker for high-risk NB and offers valuable insights for the risk classification of GNBs.

#4

Can indocyanine green fluorescence aid operative decision making in neuroblastic tumour surgery? Early experience from a single centre.

Journal of pediatric surgery2026 Feb 19

Surgery for neuroblastic tumours can entail difficult decisions about what and where to resect. Indocyanine Green(ICG) near-infrared fluorescence(NIRF) may help with decisions about resecting disease where critical structures are at risk of injury or where a total resection would cause life changing disability. We reviewed the results for all children undergoing ICG NIRF guided surgery for neuroblastic tumours in our centre. Review of single quaternary centre patients between 01/2019 and 12/2023 with a neuroblastic tumour undergoing surgical biopsy or resection with ICG NIRF. Demographics, imaging, tumour details, ICG dosing, intra-operative findings, pathology reports and follow up were reviewed. Twelve patients(6F) underwent 17 surgical procedures (12 resections and 5 biopsies). Six patients were stage L1, four patients L2 and two patients had metastatic disease. Eight patients had neuroblastoma (NBL), 2 ganglioneuroma (GN), and 1 ganglioneuroblastoma (GNBL). One case had mixed biology with multiple foci of NBL and GN. Aflourescence/hypofluorescence occurred in 8 patients with GN, GNBL or <10 % viable NBL. Hyperfluorescence was seen in three patients with primitive neuroblasts confirmed on pathology. In the patient with mixed biology, ICG NIRF showed hyperfluorescent areas (containing primitive neuroblasts) and afluorescent ones (containing GN). Following chemotherapy, all disease was afluorescent. In the fluorescent NBL lesions, NIR microscopy showed a median (IQR) tumour to background ratio (TBR) of 5.385 (4.2):1. The results of this preliminary small cohort suggest that ICG NIRF can predict the presence of primitive neuroblastic tissue and be a useful adjunct to surgical decision making.

#5

The diagnostic value of enhanced CT radiomics and deep learning in differentiating pediatric peripheral neuroblastoma from ganglioneuroblastoma.

BMC cancer2026 Feb 06

To evaluate the diagnostic value of enhanced computed tomography (CT) radiomics and deep learning in differentiating pediatric peripheral neuroblastoma (NB) from ganglioneuroblastoma (GNB). Retrospectively enrolled children with pathologically confirmed NB and GNB between February 2014 and December 2024 were randomly sampled and divided into a training set and a validation set. Radiomic features were extracted and selected from arterial-phase and venous-phase CT images. A 3D-UNet model was constructed to train a lesion segmentation model. Radiomic features were automatically extracted and selected from CT images using the 3D-UNet model. Radiomics models and combined models (incorporating clinical indicators) were established on the basis of the optimal feature subsets for the arterial phase, venous phase, arteriovenous phase, and combined clinical data. Receiver operating characteristic (ROC) curves were plotted, and the area under the curve (AUC) was calculated and compared across phases and models. A total of 225 pediatric patients (161 NB cases and 64 GNB cases) were enrolled. Compared with the radiomic-only models (LDA and LR), the combined models (LDA and LR) incorporating radiomic and clinical features (age and NSE) demonstrated greater diagnostic performance in differentiating NB and GNB. The 3D-UNet-based deep learning model achieved optimal performance after 20 training iterations, with a best Dice coefficient of 0.818 for mixed tumor types in the validation set.The optimal diagnostic performance was achieved by the LR combined model based on venous-phase CT images’ omics features and clinical data (CE2 + C), with an AUC of 0.922 in the training set and 0.913 in the validation set. Both the LDA and LR models exhibited high diagnostic efficacy, with no statistically significant difference (P > 0.05) between the models. There was also no significant difference (P > 0.05) in the diagnostic performance of the combined models across phases when incorporating clinical information. Enhanced CT radiomics and deep learning models have significant diagnostic value in differentiating pediatric peripheral NB from GNB.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC387 artigos no totalmostrando 198

2026

Telomere maintenance mechanisms are activated in ganglioneuroblastoma and ganglioneuroma.

Oncology letters
2026

[Correlation study between tumor location and pathological subtypes of neuroblastic tumors associated with opsoclonus myoclonus ataxia syndrome].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2026

Can indocyanine green fluorescence aid operative decision making in neuroblastic tumour surgery? Early experience from a single centre.

Journal of pediatric surgery
2026

The diagnostic value of enhanced CT radiomics and deep learning in differentiating pediatric peripheral neuroblastoma from ganglioneuroblastoma.

BMC cancer
2026

Pathology of peripheral neuroblastic tumors.

Diagnostic pathology
2025

Simultaneous occurrence of bilateral retroperitoneal neuroblastoma and bifocal malignant mixed germ cell tumor in a pediatric patient with 16p11.2 microdeletion syndrome: a case report.

Frontiers in endocrinology
2026

Temporal clustering of neuroblastic tumours in children and young adults from Scotland.

Environmental health : a global access science source
2026

Is There a Role for Chemotherapy in Unresectable Ganglioneuroblastoma Intermixed?: A Case Series Analysis.

Journal of pediatric hematology/oncology
2026

Copy-Number Aberrations in Circulating Tumor DNA Enable Diagnosis and Risk Stratification of Pediatric Neuroblastic Tumors.

Cancer research communications
2026

[Clinicopathological and molecular genetic features of pediatric malignant peripheral nerve sheath tumors originating from ganglioneuroma/ganglioneuroblastoma].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2025

Histologic Response to Induction Chemotherapy in High-Risk Neuroblastoma.

Cancer medicine
2025

Uncommon Location for Pelvic Ganglioneuroblastoma: Pelvic Nebenorgane.

Journal of Indian Association of Pediatric Surgeons
2025

Peripheral neural crest tumor brain metastases management: a single-institution retrospective study.

Journal of neuro-oncology
2025

Therapy-Related Acute Myeloid Leukemia with inv(16) in a Child after Chemotherapy for Previous Ganglioneuroblastoma.

Clinical laboratory
2025

Clinical and molecular findings of KMT2D-related Kabuki syndrome: A series of 13 patients with 3 novel variants.

European journal of medical genetics
2025

Pathological validation of 18F-AlF-NOTA-octreotide PET/CT for neuroblastoma.

Scientific reports
2025

Ganglioneuroblastoma with cannibalism in bone marrow.

British journal of haematology
2025

[Beckwith-Wiedemann syndrome with ganglioneuroblastoma: a case report].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2025

Predictive value of multiparametric diagnostic model based on 2-[18F]-fluoro-D-glucose (2-[18F]-FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in differentiating between neuroblastoma and ganglioneuroblastoma.

Clinical radiology
2025

A head-to-head prospective comparative analysis of 68Ga-DOTATATE PET/CT and 123I-MIBG SPECT/CT in central nervous system metastases of neuroblastoma and ganglioneuroblastoma.

European journal of nuclear medicine and molecular imaging
2025

SNP array analysis facilitates the identification of novel chromosomal alterations associated with disease and SNPs related to adverse drug reactions in neuroblastoma.

Oncology letters
2025

Diagnostic Challenges and Updates in Peripheral Neuroblastic Tumors.

Surgical pathology clinics
2025

Transperitoneal Laparoscopic Adrenalectomy in Children - Initial Experience in an Emerging Tertiary Center in Eastern India.

Journal of Indian Association of Pediatric Surgeons
2025

Tertiary Lymphoid Structures Are Associated with Progression-Free Survival of Peripheral Neuroblastic Tumor Patients.

Cancers
2025

Rubinstein-Taybi syndrome with ganglioneuroblastoma: a case report and literature review.

BMC pediatrics
2025

Confusing Onset of MOGAD in the Form of Focal Seizures.

Neurology international
2025

Stereotactic radiosurgery for brain metastases secondary to adrenal ganglioneuroblastoma: illustrative case.

Journal of neurosurgery. Case lessons
2025

Radiomics analysis based on 18F-fluorodeoxyglucose positron emission tomography/computed tomography for differentiating the histological classification of peripheral neuroblastic tumours.

Clinical radiology
2025

Positive 18 F-FDG PET/CT and Negative 123 I-MIBG SPECT/CT Imaging in an Unusual Diaphragmatic Metastasis From Ganglioneuroblastoma.

Clinical nuclear medicine
2025

Proteomic analysis reveals chromatin remodeling as a potential therapeutical target in neuroblastoma.

Journal of translational medicine
2025

A Single-Institution Analysis of Surveillance Practice for Low-Risk Neuroblastic Tumors.

The Journal of surgical research
2025

Adults and Adolescents With Neuroblastoma: An Analysis of the National Cancer Database.

Journal of surgical oncology
2025

Intraventricular ganglioneuroblastoma: an uncommon location for a rare tumour in a young adult with review of literature.

International cancer conference journal
2025

Primary Renal Neuroblastoma: A Case Report and Review of the Literature.

Current pediatric reviews
2024

Characterisation of Paediatric Neuroblastic Tumours by Quantitative Structural and Diffusion-Weighted MRI.

Journal of clinical medicine
2025

Management of Ganglioneuroma and Ganglioneuroblastoma Intermixed: A United Kingdom Children's Cancer and Leukaemia Group (UK CCLG) Nationwide Study Report.

Pediatric blood &amp; cancer
2024

Unraveling the glycosphingolipid metabolism by leveraging transcriptome-weighted network analysis on neuroblastic tumors.

Cancer &amp; metabolism
2024

Vasoactive Intestinal Peptide-Producing Neuroblastic Tumors: A Rare Cause of Refractory Diarrhea.

Cureus
2024

Primary intracranial pediatric ganglioneuroblastoma-report of two cases and review of an unusual masquerader.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2024

A case of olfactory ganglioneuroblastoma in a dog: immunohistochemical comparison with olfactory neuroepithelia and olfactory neuroblastomas.

The Journal of veterinary medical science
2024

Successful endoscopic approach for peripheral neuroblastic tumors in children.

Pediatrics international : official journal of the Japan Pediatric Society
2024

Indocyanine green fluorescence imaging-assisted laparoscopy resection of retroperitoneal tumors in children: case report and literature review.

Frontiers in pediatrics
2024

A head-to-head comparison of computed tomography- and magnetic resonance imaging-based radiomics in assessing pediatric peripheral neuroblastic tumor cell behavior.

Abdominal radiology (New York)
2024

Adolescent- and adult-onset neuroblastic tumor: A retrospective multicenter observational study of patients diagnosed in France between 2000 and 2020.

Pediatric blood &amp; cancer
2024

Development and validation of a prognostic nomogram for patients with ganglioneuroblastoma: A SEER-based study.

Heliyon
2024

Anti-Hu antibody associated paraneoplastic neurological syndrome in a child with ganglioneuroblastoma: A rare case report and literature review.

Medicine
2024

A Preliminary Study on the Application of Contrast-Enhanced Ultrasonography in Children With Peripheral Neuroblastic Tumors.

Ultrasound in medicine &amp; biology
2024

Review of neoplasia in fish at a large display aquarium, 2005-2021.

Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc
2024

Clinical features and treatment options for pediatric adrenal incidentalomas: a retrospective single center study.

BMC pediatrics
2024

Adrenal ganglioneuroblastoma with metastasis near the renal hilum in an adult female: A case report and review of the literature.

Oncology letters
2024

High-Titer Anti-ZSCAN1 Antibodies in a Toddler Clinically Diagnosed with Apparent Rapid-Onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation Syndrome.

International journal of molecular sciences
2024

Benign paraspinal ganglioneuroma with paraneoplastic opsoclonus myoclonus syndrome.

BMJ case reports
2024

Coexistence of Langerhans Cell Histiocytosis and Ganglioneuroblastoma Revealed by 18 F-FDG PET/CT in a Pediatric Patient.

Clinical nuclear medicine
2023

A geospatial assessment of industrial releases and pediatric neuroblastic tumours at diagnosis: A retrospective case series.

Archives of environmental &amp; occupational health
2025

Intracranial leptomeningeal CNS ganglioneuroblastoma. First report and review of the literature.

British journal of neurosurgery
2023

A needle in the haystack: An unusual case presentation of ganglioneuroblastoma at a tertiary care center in Coastal Karnataka.

Clinical case reports
2023

N6-methyladenosine-mediated overexpression of long noncoding RNA ADAMTS9-AS2 triggers neuroblastoma differentiation via regulating LIN28B/let-7/MYCN signaling.

JCI insight
2025

Late Relapse in Neuroblastoma: Case Report and Review of the Literature.

Current pediatric reviews
2023

Chronic Diarrhea Caused by Vasoactive Intestinal Peptide-Secreting Tumor.

Life (Basel, Switzerland)
2024

Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to 131 I-MIBG in patients with relapsed/refractory neuroblastoma.

Pediatric blood &amp; cancer
2024

Laparoscopic Transperitoneal Adrenalectomy for Adrenal Tumors in Children: Technical Considerations and Surgical Experience.

Journal of laparoendoscopic &amp; advanced surgical techniques. Part A
2023

Musashi-2 (MSI2) promotes neuroblastoma tumorigenesis through targeting MYC-mediated glucose-6-phosphate dehydrogenase (G6PD) transcriptional activation.

Medical oncology (Northwood, London, England)
2023

[Peripheral neuroblastic tumors in childhood].

Pathologie (Heidelberg, Germany)
2023

Great mimicker - a case of occult melanoma displaying ganglioneuroblastic differentiation.

Contemporary oncology (Poznan, Poland)
2023

Single-cell transcriptome sequencing reveals tumor heterogeneity in family neuroblastoma.

Frontiers in immunology
2023

Computer-assisted resection of multifocal primary neuroblastic tumors: A case report.

Asian journal of surgery
2023

Nonspecific Gastrointestinal Symptoms as the First Sign of Ganglioneuroblastoma Intermixed-Case Report and Literature Review.

Journal of clinical medicine
2023

The prognostic and predictive value of plasma D-dimer in children with neuroblastoma: a 7-year retrospective analysis at a single institution.

Annals of surgical treatment and research
2023

Maturation of metastases in peripheral neuroblastic tumors (neuroblastoma) of children.

Journal of neuropathology and experimental neurology
2023

Translational practice of fluorescence in situ hybridisation to identify neuroblastic tumours with TERT rearrangements.

The journal of pathology. Clinical research
2023

Cervical Ganglioneuroblastoma Diagnosed by 68Ga-DOTATOC PET/CT in a Child with Opsoclonus Myoclonus Syndrome.

Journal of nuclear medicine technology
2023

Clinicopathological significance of vasculogenic mimicry and fetal hemoglobin expression in peripheral neuroblastic tumors in children.

American journal of translational research
2023

Brain and Spinal Cord Tumors of Embryonic Origin.

Advances in experimental medicine and biology
2023

Embryonal Tumors of the Central Nervous System with Multilayered Rosettes and Atypical Teratoid/Rhabdoid Tumors.

Advances in experimental medicine and biology
2023

Correlations between contrast-enhanced CT-measured extracellular volume fraction, histopathological features, and MYCN amplification status in abdominal neuroblastoma: a retrospective study.

Abdominal radiology (New York)
2023

Computer-assisted rescue of the inferior mesenteric artery in a child with a giant ganglioneuroblastoma: A case report.

World journal of gastrointestinal surgery
2024

Gastric Ganglioneuroblastoma in an Elderly man: A Case Report and Literature Review.

International journal of surgical pathology
2023

Ganglioneuroblastoma intermixed: Clinicopathological implications of diagnosis at presentation and genomic correlations.

Pediatric blood &amp; cancer
2023

Identification and validation of radiomic features from computed tomography for preoperative classification of neuroblastic tumors in children.

BMC pediatrics
2023

Outcomes and Histological Variations of Neuroblastoma and Ganglioneuroblastoma with Paraneoplastic Syndromes.

The American surgeon
2023

An infantile pineal embryonal tumor showing pathological features of a CNS ganglioneuroblastoma and the methylation profiling of an atypical teratoid/rhabdoid tumor and SMARCA4 mutation.

Journal of neuropathology and experimental neurology
2023

Extra-adrenal peripheral neuroblastic tumors: A clinicopathological study of 18 cases.

Indian journal of pathology &amp; microbiology
2023

Clinical value of 18F-FDG PET/CT to predict MYCN gene, chromosome 1p36 and 11q status in pediatric neuroblastoma and ganglioneuroblastoma.

Frontiers in oncology
2024

Five Years Follow-up of Opsoclonus-Myoclonus-Ataxia Syndrome-Associated Neurogenic Tumors in Children.

Neuropediatrics
2023

A male with ganglioneuroblastoma cerebrospinal hemorrhages, cardiomyopathy, and retinopathy due to severe hypertension.

Pediatric blood &amp; cancer
2023

Whole-tumor radiomics analysis of T2-weighted imaging in differentiating neuroblastoma from ganglioneuroblastoma/ganglioneuroma in children: an exploratory study.

Abdominal radiology (New York)
2023

Pathological and clinical outcomes of adrenalectomy: A multi-center experience in Saudi Arabia.

Saudi journal of biological sciences
2023

Paediatric metastatic ganglioneuroblastoma on 68Ga-DOTA NOC PET-CT.

JPMA. The Journal of the Pakistan Medical Association
2023

Adrenal Ganglioneuroblastoma of Adult Onset: A Literature Review.

Cureus
2023

ANNA-1-associated paraneoplastic limbic encephalitis in a patient with pelvic ganglioneuroblastoma.

Seminars in roentgenology
2023

Ganglioneuroblastoma Presenting as Obstructive Sleep Apnea in a 5-Year-Old Boy.

The Journal of craniofacial surgery
2022

Comparing the diagnostic value of 18F-FDG PET/CT scan and bone marrow biopsy in newly diagnosed pediatric neuroblastoma and ganglioneuroblastoma.

Frontiers in oncology
2022

Giant tumors of the posterior mediastinum: a narrative review of surgical treatment.

Mediastinum (Hong Kong, China)
2022

The Pitfall of Ganglioneuroblastoma-Nodular Diagnosis: Clinical and Imaging Considerations over a Rare Bifocal Sporadic Case.

Diagnostics (Basel, Switzerland)
2023

Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity.

Cellular oncology (Dordrecht, Netherlands)
2022

Rapid-Onset Obesity, Hypothalamic Dysregulation, Hypoventilation, Autonomic Dysregulation, and Neuroendocrine Tumour: Rare Syndrome with Myriad Anaesthesia Implications.

Turkish journal of anaesthesiology and reanimation
2022

Neuroblastic tumors and neurofibromatosis type 1: A retrospective multicenter study in Italy and systematic review of the literature.

Frontiers in pediatrics
2023

Blueberry muffin baby secondary to ganglioneuroblastoma.

Pediatric dermatology
2022

Ganglioneuroblastoma arising in a Mature Cystic Teratoma of Ovary: Report and Literature review of an uncommon neoplasm.

Gynecologic oncology reports
2022

Comparison of mediastinal and non-mediastinal neuroblastoma and ganglioneuroblastoma associated with opsoclonus-myoclonus syndrome: a systematic review and meta-analysis.

Translational cancer research
2022

Composite pheochromocytoma-ganglioneuroma: a case with two distinct components radiographically.

BJR case reports
2023

Determination of Catecholamines in a Small Volume (25 μL) of Plasma from Conscious Mouse Tail Vein.

Methods in molecular biology (Clifton, N.J.)
2022

Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory.

Cell reports
2023

Relationship between the timing of chemotherapy and surgical complications following surgical biopsy in children with malignant solid tumors.

Pediatric blood &amp; cancer
2022

Long-term survival outcomes of pediatric adrenal malignancies: An analysis with the upstaged SEER registry during 2000-2019.

Frontiers in endocrinology
2022

Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2022

Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting.

Cancer
2022

Developmental disorders affecting the respiratory system: CCHS and ROHHAD.

Handbook of clinical neurology
2022

Pathological prognosis classification of patients with neuroblastoma using computational pathology analysis.

Computers in biology and medicine
2022

Clinical and surgical outcome differences on the basis of pathology category in cervical neuroblastic tumors.

Journal of pediatric surgery
2022

Management of Primary Thoracic Neuroblastic Tumors in Children: An Observational Study.

Journal of Indian Association of Pediatric Surgeons
2023

Early and Aggressive Treatment May Modify Anti-Hu Associated Encephalitis Prognosis.

Neuropediatrics
2022

Retroperitoneal ganglioneuroblastoma with postoperative stress ulcer perforation in an adolescent: A case report and review of the literature.

Oncology letters
2023

A Rare Case of a Solitary Fibrous Tumor in a Child, Presenting as a Congenital Mass, Displaying NAB2ex4::STAT6ex2 Gene Fusion with an Incidental Ganglioneuroblastoma.

International journal of surgical pathology
2022

Neuroblastic Tumors of the Adrenal Gland in Elderly Patients: A Case Report and Review of the Literature.

Frontiers in pediatrics
2023

Ewing Sarcoma Displaying Extensive Well Differentiated Neuroblastomatous Differentiation: A Case Report.

Fetal and pediatric pathology
2024

Ganglioneuroblastoma in the Retropharyngeal Space: A Case Report and Literature Review.

Ear, nose, &amp; throat journal
2022

Primary Spinal Tumors and Masses in Children.

Iranian journal of child neurology
2023

Ganglioneuroblastoma in a Child With Neurofibromatosis Type 1: A Case Report and Literature Review.

Journal of pediatric hematology/oncology
2022

Ganglion cell maturation in peripheral neuroblastic tumours of children.

Clinical neuropathology
2021

Robotics-Assisted Pediatric Oncology Surgery-A Preliminary Single-Center Report and a Systematic Review of Published Studies.

Frontiers in pediatrics
2022

Exploring the prognosis of neuroblastoma in adolescents and adults: a case series and literature review.

Neoplasma
2022

Genetic and Histopathological Heterogeneity of Neuroblastoma and Precision Therapeutic Approaches for Extremely Unfavorable Histology Subgroups.

Biomolecules
2021

Risk of developing second malignant neoplasms in patients with neuroblastoma: a population study of the US SEER database.

Radiation oncology (London, England)
2021

[Computed tomography-based radiomics for differential of retroperitoneal neuroblastoma and ganglioneuroblastoma in children].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University
2021

Clinical Analysis of Pediatric Opsoclonus-Myoclonus Syndrome in One of the National Children's Medical Center in China.

Frontiers in neurology
2022

Anatomic patterns of relapse and progression following treatment with 131 I-MIBG in relapsed or refractory neuroblastoma.

Pediatric blood &amp; cancer
2021

Adrenal ganglioneuroma: Prognostic factors (Review).

Experimental and therapeutic medicine
2022

Unique case of adult onset posterior mediastinal ganglioneuroblastoma on 68Ga DOTATATE PET/CT.

Revista espanola de medicina nuclear e imagen molecular
2021

Duodenal Ganglioneuroma: A Rare Tumor Causing Upper Gastrointestinal Bleed.

Surgery journal (New York, N.Y.)
2022

Minimally invasive surgery for neuroblastic tumours: A SIOPEN multicentre study: Proposal for guidelines.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2021

Composite Neuroblastoma Metastatic to a Lymph Node: The Novel Histopathologic Diagnosis of a Unique Multiclonal Neoplasm.

Annals of clinical and laboratory science
2021

Adrenal ganglioneuroma resected for suspicious malignancy: multicenter review of 25 cases and review of the literature.

Annals of surgical treatment and research
2021

Composite phaeochromocytoma with malignant peripheral nerve sheath tumour: A case report with summary of prior published cases.

Indian journal of pathology &amp; microbiology
2022

The Relevance of Preoperative Identification of the Adamkiewicz Artery in Posterior Mediastinal Pediatric Tumors.

Annals of surgical oncology
2021

Primary orbital ganglioneuroblastoma: A case report.

Open medicine (Warsaw, Poland)
2021

A rare case of adrenal ganglioneuroblastoma-intermixed in an adult and a review of literature.

Radiology case reports
2021

Unresectable thoracic neuroblastic tumors: Changes in image-defined risk factors after chemotherapy and impact on surgical management.

Pediatric blood &amp; cancer
2022

Characteristics of benign neuroblastic tumors: Is surgery always necessary?

Journal of pediatric surgery
2022

Mediastinal neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: Pathology review and diagnostic approach.

Seminars in diagnostic pathology
2021

Olfactory ganglioneuroblastoma in a dog: case report and literature review.

Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc
2022

A Metastatic Neuroblastic Tumor in a 28-Month-old Boy: Unusual Spontaneous Regression From Neuroblastoma to Ganglioneuroma?

Journal of pediatric hematology/oncology
2021

Coexistence of orbital rhabdomyosarcoma and adrenal neuroblastic tumor in a child.

Pediatrics international : official journal of the Japan Pediatric Society
2021

Metastatic Neuroblastoma Presenting as a Submandibular Mass with Mandibular Bone Involvement in a Three-Year-Old Child.

International journal of environmental research and public health
2022

Refractory Stage M Ganglioneuroblastoma With Bone Metastases and a Favorable, Chronic Course of Disease: Description of a Patient Cohort.

Journal of pediatric hematology/oncology
2022

Primary cervical ganglioneuroblastoma, nodular subtype.

Auris, nasus, larynx
2021

Clinical and Pathological Evidence of Anti-GD2 Immunotherapy Induced Differentiation in Relapsed/Refractory High-Risk Neuroblastoma.

Cancers
2022

Composite phaeochromocytomas-a systematic review of published literature.

Langenbeck's archives of surgery
2021

Primary uterine ectomesenchymoma harboring a DICER1 mutation: case report with molecular analysis.

Virchows Archiv : an international journal of pathology
2021

Expression of BARD1 β Isoform in Selected Pediatric Tumors.

Genes
2021

Primary renal ganglioneuroblastoma mimicking Wilms' tumor in a 3-year-old girl.

Pediatrics international : official journal of the Japan Pediatric Society
2021

Diagnostic values of 68Ga-labelled DOTANOC PET/CT imaging in pediatric patients presenting with paraneoplastic opsoclonus myoclonus ataxia syndrome.

European radiology
2020

Feasibility and possible value of quantitative semi-automated diffusion weighted imaging volumetry of neuroblastic tumors.

Cancer imaging : the official publication of the International Cancer Imaging Society
2020

A Rare Cause of Sleep-Disordered Breathing: ROHHAD Syndrome.

Frontiers in pediatrics
2021

Association of image-defined risk factors with clinical features, histopathology, and outcomes in neuroblastoma.

Cancer medicine
2020

Comparison of Incidence and Outcomes of Neuroblastoma in Children, Adolescents, and Adults in the United States: A Surveillance, Epidemiology, and End Results (SEER) Program Population Study.

Medical science monitor : international medical journal of experimental and clinical research
2020

New Prognostic Indicators in Pediatric Adrenal Tumors: Neuroblastoma and Adrenal Cortical Tumors, Can We Predict When These Will Behave Badly?

Surgical pathology clinics
2021

Incidence of Horner syndrome associated with neuroblastic disease.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2020

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma.

BMC medical genomics
2020

Primary orbital ganglioneuroblastoma in a child: A case report.

Medicine
2021

Harlequin syndrome associated with ganglioneuroblastoma-induced Horner syndrome.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2020

Robotic adrenalectomy in the pediatric population: initial experience case series from a tertiary center.

BMC urology
2020

Brain paraneoplastic syndromes in a patient with mediastinal ganglioneuroma.

Radiology case reports
2021

MYC-associated protein X binding with the variant rs72780850 in RNA helicase DEAD box 1 for susceptibility to neuroblastoma.

Science China. Life sciences
2020

Retrospective accuracy analysis of MRI based lesion size measurement in neuroblastic tumors: which sequence should we choose?

BMC medical imaging
2020

Diagnostic Use of Post-therapy 131I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma.

Diagnostics (Basel, Switzerland)
2020

High-dose 131I-mIBG as consolidation therapy in pediatric patients with relapsed neuroblastoma and ganglioneuroblastoma: the Japanese experience.

Annals of nuclear medicine
2020

Rare Cases of Pediatric Vasoactive Intestinal Peptide Secreting Tumor With Literature Review: A Challenging Etiology of Chronic Diarrhea.

Frontiers in pediatrics
2020

Primary round cell sarcomas of the urinary bladder with EWSR1 rearrangement: a multi-institutional study of thirteen cases with a review of the literature.

Human pathology
2020

Retroperitoneal Ganglioneuroma in a Patient Presenting With Vague Abdominal Pain.

Cureus
2020

Ganglioneuromas are driven by activated AKT and can be therapeutically targeted with mTOR inhibitors.

The Journal of experimental medicine
2020

Adult-onset ganglioneuroblastoma of the posterior mediastinum with osseous metastasis.

Radiology case reports
2020

Central nervous system ganglioneuroblastoma harboring MYO5A-NTRK3 fusion.

Brain tumor pathology
2020

A Novel MAX Gene Mutation Variant in a Patient With Multiple and "Composite" Neuroendocrine-Neuroblastic Tumors.

Frontiers in endocrinology
2020

Neurogenic Tumors of the Mediastinum.

Seminars in diagnostic pathology
2020

ROHHAD(NET) Syndrome: Systematic Review of the Clinical Timeline and Recommendations for Diagnosis and Prognosis.

The Journal of clinical endocrinology and metabolism
2020

Embryonal Tumors of the Central Nervous System: An Update.

Surgical pathology clinics
2020

Incidence, Treatment, and Survival in Primary Central Nervous System Neuroblastoma.

World neurosurgery
2020

Suprasellar central nervous system ganglioneuroblastoma: a case in a 9-year-old child and review of the literature.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2020

Incidence and outcomes of neuroblastoma in Australian children: A population-based study (1983-2015).

Journal of paediatrics and child health
2020

Pediatric neuroblastic tumors: A critical evaluation of cytomorphological features for risk stratification on aspiration cytology.

Diagnostic cytopathology
2020

Tatton-Brown-Rahman syndrome: Six individuals with novel features.

American journal of medical genetics. Part A
2020

Biomarker recommendation for PD-1/PD-L1 immunotherapy development in pediatric cancer based on digital image analysis of PD-L1 and immune cells.

The journal of pathology. Clinical research
2020

Therapeutic results in three cases of ganglioneuroblastoma associated with opsoclonus myoclonus ataxia syndrome.

Indian journal of cancer
2020

Posterior mediastinal ganglioneuroblastoma in an adolescent: A case report and review.

Thoracic cancer
2021

Importance of Magnetic Resonance Imaging With Diffusion-weighted Imaging in Guiding Biopsy of Nodular Ganglioneuroblastoma: A Case Report.

Journal of pediatric hematology/oncology
2019

Resection of a thoracoabdominal ganglioneuroma via a retroperitoneal minimally invasive approach.

Journal of pediatric surgery case reports
2019

Exome sequencing identifies predisposing and fusion gene in ganglioneuroma, ganglioneuroblastoma and neuroblastoma.

Mathematical biosciences and engineering : MBE
2019

Minimally Invasive Surgery for Pediatric Adrenal Masses-Report on Four Cases.

European journal of pediatric surgery reports
2020

The ganglioside GD2 as a circulating tumor biomarker for neuroblastoma.

Pediatric blood &amp; cancer
2019

A single-institution experience of neurogenic tumors of the mediastinum.

Asian cardiovascular &amp; thoracic annals
2019

β2‑adrenergic receptor signaling promotes neuroblastoma cell proliferation by activating autophagy.

Oncology reports
2019

FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma.

Journal of experimental &amp; clinical cancer research : CR
2019

Diagnostic value of whole-body MRI in Opsoclonus-myoclonus syndrome: a clinical case series (3 case reports).

BMC medical imaging
2019

Case report of severe psychiatric sequelae in a 16-year-old female following resection of a purely dopamine-secreting ganglioneuroma.

International journal of surgery case reports
2019

Results of a prospective clinical trial JN-L-10 using image-defined risk factors to inform surgical decisions for children with low-risk neuroblastoma disease: A report from the Japan Children's Cancer Group Neuroblastoma Committee.

Pediatric blood &amp; cancer
2019

Congenital malformation syndromes associated with peripheral neuroblastic tumors: A systematic review.

Pediatric blood &amp; cancer
2019

Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification.

Cytopathology : official journal of the British Society for Clinical Cytology
Ver todos os 387 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Ganglioneuroblastoma.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Ganglioneuroblastoma

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ainda não achamos doenças com sintomas parecidos o suficiente.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. [Correlation study between tumor location and pathological subtypes of neuroblastic tumors associated with opsoclonus myoclonus ataxia syndrome].
    Zhonghua er ke za zhi = Chinese journal of pediatrics· 2026· PMID 41834205mais citado
  2. Temporal clustering of neuroblastic tumours in children and young adults from Scotland.
    Environmental health : a global access science source· 2026· PMID 41580800mais citado
  3. Telomere maintenance mechanisms are activated in ganglioneuroblastoma and ganglioneuroma.
    Oncology letters· 2026· PMID 41858373mais citado
  4. Can indocyanine green fluorescence aid operative decision making in neuroblastic tumour surgery? Early experience from a single centre.
    Journal of pediatric surgery· 2026· PMID 41722683mais citado
  5. The diagnostic value of enhanced CT radiomics and deep learning in differentiating pediatric peripheral neuroblastoma from ganglioneuroblastoma.
    BMC cancer· 2026· PMID 41652556mais citado
  6. Infantile Ganglioneuroblastoma Causing Growth Failure and Hypertensive Cardiomyopathy From Excessive Catecholamine Production.
    J Pediatr Hematol Oncol· 2026· PMID 41891982recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:251877(Orphanet)
  2. MONDO:0005035(MONDO)
  3. GARD:20719(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q5521151(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Ganglioneuroblastoma
Compêndio · Raras BR

Ganglioneuroblastoma

ORPHA:251877 · MONDO:0005035
Prevalência
<1 / 1 000 000
Casos
425 casos conhecidos
Herança
Not applicable
CID-10
C71.9 · Neoplasia maligna do encéfalo, não especificado
CID-11
Ensaios
17 ativos
Início
Childhood, Infancy
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0206718
Repurposing
2 candidatos
cyclophosphamideDNA alkylating agent
iobenguaneantineoplastic agent
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades